Author

J. Perreault

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 5 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:human· 4 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 3 Organism:bacteria (other)· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. Finzi· 4 shared J. Prevost· 4 shared R. Bazin· 4 shared A. Lewin· 3 shared G. Beaudoin-Bussieres· 3 shared J. Richard· 3 shared T. Tremblay· 3 shared A. Laumaea· 2 shared

Activity by Year

2020-2023 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

A. Finzi

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Differentiating Bacillus subtilis incorporates valine and methionine carbon into the backbone of specific fatty acids

G. E. Rowe, J. Perreault

The paper shows that Bacillus subtilis incorporates deuterium and 13C-labeled valine and methionine into specific fatty acid backbones during sporulation.

bioRxiv · Apr 14, 2023 · PreprintMicrobiology

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses

D. Chatterjee, A. Tauzin, L. Marchitto, S. Y. Gong, M. Boutin, C. Bourassa, G. Beaudoin-Bussieres, Y. Bo, S. Ding, A. Laumaea, D. Vezina, J. Perreault, L. Gokool, C. Morrisseau, P. Arlotto, , A. Finzi

This study evaluates how plasma from individuals with a 16-week interval between BNT162b2 mRNA vaccine doses recognizes and neutralizes the Omicron Spike compared to other variants.

bioRxiv · Dec 21, 2021Microbiology

High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples

S. P. Anand, J. Prevost, J. Richard, J. Perreault, T. Tremblay, M. Drouin, M.-J. Fournier, A. Lewin, R. Bazin, A. Finzi

This study tracks the decline of antibodies against the full-length SARS-CoV-2 Spike in convalescent plasma over time, showing a gradual decrease correlated with RBD-specific antibodies and days post-infection.

bioRxiv · Oct 20, 2020Microbiology

Longitudinal analysis of the humoral response to SARS-CoV-2 spike RBD in convalescent plasma donors

J. Perreault, T. Tremblay, M.-J. Fournier, M. Drouin, G. Beaudoin-Bussieres, J. Prevost, A. Lewin, P. Begin, A. Finzi, R. Bazin

The paper tracks antibody levels against SARS-CoV-2 RBD in convalescent plasma donors over time, finding a decline in antibodies after ~76 days post-symptoms onset.

bioRxiv · Jul 16, 2020 · PreprintImmunology

An experimentally evolved variant of RsmA confirms its central role in the control of Pseudomonas aeruginosa social motility

S. Robitaille, Y. Lopez de los Santos, M.-C. Groleau, F. Jean-Pierre, N. Doucet, J. Perreault, E. Deziel

This study uses experimental evolution to identify mutations in gacA and rsmA that rescue a swarming defect in a Pseudomonas aeruginosa mutant, confirming RsmA's central role in social motility.

bioRxiv · Jul 15, 2020 · PreprintMicrobiology

Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike

J. Prevost, R. Gasser, G. Beaudoin-Bussieres, J. Richard, R. Duerr, A. Laumaea, S. P. Anand, G. Goyette, M. Benlarbi, S. Ding, H. Medjahed, A. Lewin, J. Perreault, T. Tremblay, G. Gendron-Lepage, , A. Finzi

This study evaluates humoral responses against SARS-CoV-2 Spike in 106 infected individuals, finding persistent RBD-specific IgG and declining neutralizing activity over time.

bioRxiv · Jun 8, 2020Microbiology